Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Covington
Colorcon
Medtronic
Cipla
Accenture
AstraZeneca
Chinese Patent Office
US Army

Generated: February 24, 2018

DrugPatentWatch Database Preview

FAMVIR Drug Profile

« Back to Dashboard

Which patents cover Famvir, and what generic alternatives are available?

Famvir is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in FAMVIR is famciclovir. There are eight drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the famciclovir profile page.

US Patents and Regulatory Information for FAMVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis FAMVIR famciclovir TABLET;ORAL 020363-003 Dec 11, 1995 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-002 Jun 29, 1994 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FAMVIR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis FAMVIR famciclovir TABLET;ORAL 020363-002 Jun 29, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-003 Dec 11, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-003 Dec 11, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-002 Jun 29, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-003 Dec 11, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis FAMVIR famciclovir TABLET;ORAL 020363-001 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FAMVIR
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 125 mg, 250 mg and 500 mg ➤ Subscribe 12/28/2004

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Teva
Boehringer Ingelheim
UBS
Fuji
Accenture
Citi
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot